These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23774884)

  • 1. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective.
    Aliberti S; Cilloniz C; Chalmers JD; Zanaboni AM; Cosentini R; Tarsia P; Pesci A; Blasi F; Torres A
    Thorax; 2013 Nov; 68(11):997-9. PubMed ID: 23774884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.
    Aliberti S; Di Pasquale M; Zanaboni AM; Cosentini R; Brambilla AM; Seghezzi S; Tarsia P; Mantero M; Blasi F
    Clin Infect Dis; 2012 Feb; 54(4):470-8. PubMed ID: 22109954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a clinical risk score for predicting drug-resistant bacterial pneumonia in older Chinese patients.
    Ma HM; Ip M; Woo J; Hui DS
    Respirology; 2014 May; 19(4):549-55. PubMed ID: 24661357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed risk factors for infection with multidrug-resistant pathogens in hemodialysis patients hospitalized with pneumonia.
    Song JU; Park HK; Kang HK; Lee J
    BMC Infect Dis; 2017 Oct; 17(1):681. PubMed ID: 29025395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Performance of Risk Factors for Multidrug-Resistant Pathogens in Nosocomial Pneumonia.
    Dominedò C; Ceccato A; Niederman M; Cillóniz C; Gabarrús A; Martin-Loeches I; Ferrer M; Antonelli M; Torres A
    Ann Am Thorac Soc; 2021 May; 18(5):807-814. PubMed ID: 33264575
    [No Abstract]   [Full Text] [Related]  

  • 7. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia.
    Shorr AF; Zilberberg MD; Micek ST; Kollef MH
    Arch Intern Med; 2008 Nov; 168(20):2205-10. PubMed ID: 19001196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a scoring tool to predict drug-resistant pathogens in hospitalised pneumonia patients.
    Park SC; Kim EY; Kang YA; Park MS; Kim YS; Kim SK; Chang J; Jung JY
    Int J Tuberc Lung Dis; 2013 May; 17(5):704-9. PubMed ID: 23575340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia.
    Falcone M; Russo A; Giannella M; Cangemi R; Scarpellini MG; Bertazzoni G; Alarcón JM; Taliani G; Palange P; Farcomeni A; Vestri A; Bouza E; Violi F; Venditti M
    PLoS One; 2015; 10(4):e0119528. PubMed ID: 25860142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCAP not busy being born is busy dying.
    Ewig S
    Am J Respir Crit Care Med; 2014 Feb; 189(3):365-6. PubMed ID: 24484341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Predictors of drug-resistant pathogens in community-onset pneumonia: Are factors considered in health-care-associated pneumonia useful in the emergency department?].
    Torres Bonafonte OH; Gil Olivas E; Pérez Macho E; Pacho Pacho C; Mateo Roca M; Casademont Pou J; Ruiz Hidalgo D
    Emergencias; 2017 Oct; 29(5):306-312. PubMed ID: 29077289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization.
    Garcia-Vidal C; Viasus D; Roset A; Adamuz J; Verdaguer R; Dorca J; Gudiol F; Carratalà J
    Clin Microbiol Infect; 2011 Nov; 17(11):1659-65. PubMed ID: 21463391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
    Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y
    Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan.
    Wu CL; Ku SC; Yang KY; Fang WF; Tu CY; Chen CW; Hsu KH; Fan WC; Lin MC; Chen W; Ou CY; Yu CJ
    J Formos Med Assoc; 2013 Jan; 112(1):31-40. PubMed ID: 23332427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antibiotic decision-making tool for patients with pneumonia admitted to a medical intensive care unit.
    Huang SF; Chang JS; Sheu CC; Liu YT; Lin YC
    Int J Antimicrob Agents; 2016 Sep; 48(3):286-91. PubMed ID: 27444117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.
    Polverino E; Torres A; Menendez R; Cillóniz C; Valles JM; Capelastegui A; Marcos MA; Alfageme I; Zalacain R; Almirall J; Molinos L; Bello S; Rodríguez F; Blanquer J; Dorado A; Llevat N; Rello J;
    Thorax; 2013 Nov; 68(11):1007-14. PubMed ID: 24130227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit.
    Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR
    Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD; Shorr AF
    J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sources of multidrug-resistant Acinetobacter baumannii and its role in respiratory tract colonization and nosocomial pneumonia in intensive care unit patients.
    Huang J; Chen EZ; Qu HP; Mao EQ; Zhu ZG; Ni YX; Han LZ; Tang YQ
    Chin Med J (Engl); 2013; 126(10):1826-31. PubMed ID: 23673094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.